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Abstract 
 
Functional neuroimaging techniques have transformed our ability to probe the neurobiological 
basis of behaviour and are increasingly being applied by the wider neuroscience community. 
However, concerns have recently been raised that the conclusions drawn from some human 
neuroimaging studies are either spurious or not generalizable. Problems such as low statistical 
power, flexibility in data analysis, software errors, and lack of direct replication apply to many 
fields, but perhaps particularly to fMRI. Here we discuss these problems, outline current and 
suggested best practices, and describe how we think the field should evolve to produce the 
most meaningful answers to neuroscientific questions. 
 
 
Main text 
 
Neuroimaging, particularly using functional magnetic resonance imaging (fMRI), has become 
the primary tool of human neuroscience1, and recent advances in the acquisition and analysis of 
fMRI data have provided increasingly powerful means to dissect brain function.  The most 
common form of fMRI (known as “blood oxygen level dependent” or BOLD fMRI) measures 
brain activity indirectly through localized changes in blood oxygenation that occur in relation to 
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synaptic signaling2.  These signal changes provide the ability to map activation in relation to 
specific mental processes, identify functionally connected networks from resting fMRI3, 
characterize neural representational spaces4, and decode or predict mental function from brain 
activity5,6.  These advances promise to offer important insights into the workings of the human 
brain, but also generate the potential for a “perfect storm” of irreproducible results.  In particular, 
the high dimensionality of fMRI data, relatively low power of most fMRI studies, and the great 
amount of flexibility in data analysis all potentially contribute to a high degree of false positive 
findings.   
 
Recent years have seen intense interest in the reproducibility of scientific results and the degree 
to which some problematic yet common research practices may be responsible for high rates of 
false findings in the scientific literature, particularly within psychology but also more generally7–9.  
There is growing interest in “meta-research”10, and a corresponding growth in studies 
investigating factors that contribute to poor reproducibility. These factors include study design 
characteristics which may introduce bias, low statistical power, and flexibility in data collection, 
analysis, and reporting — termed “researcher degrees of freedom” by Simmons and 
colleagues8. There is clearly concern that these issues may be undermining the value of science 
– in the UK, the Academy of Medical Sciences recently convened a joint meeting with a number 
of other funders to explore these issues, while in the US the National Institutes of Health has an 
ongoing initiative to improve research reproducibility11. 
 
In this article we outline a number of potentially problematic research practices in neuroimaging 
that can lead to increased risk of false or exaggerated results. For each problematic research 
practice, we propose a set of solutions. While most proposed solutions are uncontroversial in 
principle, their implementation is often challenging for the research community and best 
practices are not necessarily followed. Many of these solutions arise from the experience of 
other fields with similar problems (particularly those dealing with similarly large and complex 
data sets, such as genetics; Box 1). We would note that while our discussion here focuses on 
functional MRI, many of the same issues are relevant for other types of neuroimaging, such as 
structural or diffusion MRI. 
 
Statistical power 
 
The analyses of Button and colleagues12 provided a wake-up call regarding statistical power in 
neuroscience, particularly by highlighting the point (raised earlier by Ioannidis7) that low power 
not only reduces the likelihood of finding a true result if it exists, but also raises the likelihood 
that any positive result is false, as well as causing substantial inflation of observed positive 
effect sizes13.  In the context of neuroimaging, Button and colleagues considered only structural 
MRI studies.  In order to assess the current state of statistical power in fMRI studies, we 
performed an analysis of sample sizes and the resulting statistical power of fMRI studies over 
the past 20 years.  
 
To gain a perspective on how sample sizes have changed over this time period, we obtained 
sample sizes from fMRI studies using two sources.  First, manually annotated sample size data 
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for 583 studies were obtained from published meta-analyses14.  Second, sample sizes were 
automatically extracted from the Neurosynth database15 for 548 studies published between 
2011 and 2015 (by searching for regular expressions reflecting sample size, e.g. “13 subjects”, 
“n=24”) and then manually annotated to confirm automatic estimates and identify single-group 
versus multiple-group studies. (Data and code to generate all figures in this paper are available 
from the Open Science Framework at https://osf.io/spr9a/.) Figure 1a shows that sample sizes 
have steadily increased over the past two decades, with the median estimated sample size for a 
single-group fMRI study in 2015 at 28.5. A particularly encouraging finding from this analysis is 
that the number of recent studies with large samples (greater than 100) is rapidly increasing 
(from 8 in 2012 to 17 in 2015, in the studied sample), suggesting that the field may be 
progressing towards adequately powered research. On the other hand, the median group size in 
2015 for fMRI studies with multiple groups was 19 subjects, which is below even the absolute 
minimum sample size of 20 per cell proposed by Simonsohn et al.8. 
 
In order to assess the implications of these results for statistical power, for each of the 1131 
sample sizes shown in Figure 1a we estimated the standardized effect size that would be 
required to detect an effect with 80% power (the standard level of power for most fields) for a 
whole-brain linear mixed-effects analysis using a voxelwise 5% familywise error (FWE) rate 
threshold from random field theory16 (a standard thresholding level for neuroimaging studies). In 
other words, we found the minimum effect size that would have been needed in each of these 
studies in order for the difference to be considered statistically significant with an 80% 
probability, given the sample size.  We quantify the standardised effect size using Cohen’s D, 
computed as the average effect divided by the standard deviation for the data. 
 
To do this, we assumed that each study used a statistical map with T-values in an MNI152 
(Montreal Neurological Institute) template space with smoothness of three times the voxel size 
(full width at half maximum), a commonly used value for smoothness in fMRI analysis.  The 
MNI152 template is a freely available template, obtained from an average T1 scan for 152 
subjects with a resolution of 2 millimeters and a volume within the brain mask of 228483 voxels, 
used by default in most fMRI analysis software. We assume that in each case there would be 
one active region, with voxelwise standardised effect size D; that is, we assume that for each 
subject, all voxels in the active region are on average D standardised units higher in their 
activity than the voxels in the non-active region, and that the active region is 1,600 mm2 (200 
voxels).  To calculate the voxelwise statistical significance threshold for the active region in this 
model statistical map, we used the function ptoz from the FSL17 software package, which 
computes a FWE threshold for a given volume and smoothness using the Euler Characteristic 
derived from Gaussian random field theory 18. This approach ensures that the probability of a 
voxel in the non-active brain region exceeding this significance threshold is controlled at 5%; the 
resulting significance threshold, tα, is equal to 5.12. 
 
--- Figure 1 about here --- 
 
The statistical power is defined as the probability that the local maximum peak of activation in 
the active region exceeds this significance threshold. This probability was computed using a 
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shifted version of the null local maximum distribution, with shift of D*sqrt(n) to reflect a given 
effect size and sample size. The median effect size needed to exceed the significance threshold 
in each of the studies was found by selecting the effect size D that results in statistical power 
higher than 0.80 as computed in the previous step. 
 
Figure 1b shows the median effect sizes needed to establish significance, with 80% power and 
alpha = 0.05. Despite the decreases in these hypothetical required effect sizes over the past 20 
years, Fig. 1b shows that in 2015 the median study is only sufficiently powered to detect 
relatively large effects of greater than ~0.75. Given that many of the studies will be assessing 
group differences or brain activity–behaviour correlations (which will inherently have lower 
power than average group activation effects), this represents an optimistic lower bound on the 
powered effect size.  
 
Indeed, the analysis presented in Box 2 demonstrates that typical effect sizes observed in task-
related BOLD imaging studies fall well below this level. Briefly, we analysed BOLD data from 
186 individuals who were imaged using fMRI while performing motor, emotion, working memory 
and gambling tasks as part of the Human Connectome Project19. Assessing effect sizes in fMRI 
requires the definition of an independent region of interest that captures the expected area of 
activation within which the effect size can be measured.  While there are a number of 
approaches to defining regions 20,21, we created masks defined by the intersection between 
functional activation (identified from Neurosynth.org as regions consistently active in studies 
examining the effects of ‘motor’, ‘emotion’, ‘gambling’ and ‘working memory’ tasks) and 
anatomical masks (defined using the Harvard–Oxford probabilistic atlas22, based on the 
published regions of interest from the HCP)23 . Within these intersection masks, we then 
determined the average task-related increases in BOLD signal — and the effect size (Cohen’s 
D) — associated with each different task. Additional details are provided in Box 2. The figure in 
Box 2, which lists the resulting BOLD signal changes and inferred effect sizes, demonstrates 
that realistic effect sizes  – i.e. BOLD changes associated with a range of cognitive tasks -  in 
fMRI are surprisingly small: even for powerful tasks such as the motor task which evokes 
median signal changes of greater than 4%, 75% of the voxels in the masks have a standardised 
effect size smaller than 1.  For more subtle tasks, such as gambling, only 10% of the voxels in 
our masks demonstrated standardised effect sizes larger than 0.5.  Thus the average fMRI 
study remains poorly powered for capturing realistic effects, particularly given that the HCP data 
are of particularly high quality, and thus the present estimates are likely greater than what would 
be found with most standard fMRI datasets. 
 
Solutions. 
When possible, all sample sizes should be justified by an a priori power analysis. A number of 
tools are available to enable power analyses for fMRI (for example, neuropowertools.org (see 
Further information; described in ref 24) and fmripower.org (see Further information; described in 
ref. 25). However, one must be cautious in extrapolating effect sizes from small studies, because 
they are almost certain to be inflated. When previous data are not available to support a power 
analysis, one can instead identify the sample size that would support finding the minimum effect 
size that would be theoretically informative (e.g. based on results from Box 2). The use of 
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heuristic sample size guidelines (for example, based on sample sizes used in previously 
published studies) is likely to result in a misuse of resources, either by collecting too many or 
(more likely) too few subjects.  
 
The larger sample sizes that will result from use of power analysis will have significant 
implications for researchers: Given that research funding will likely not increase to 
accommodate these larger samples, this implies that fewer studies will be funded, and that 
researchers with fewer resources will have a more difficult time performing research that meets 
these standards. This will hit trainees and junior researchers particularly hard, and the 
community needs to develop ways to address this challenge. We do not believe that the solution 
is to admit weakly powered studies simply because of a lack of resources.  This situation is in 
many ways similar to the one faced in the field of genetics, which realized more than a decade 
ago that weakly-powered genetic association studies were unreliable, and moved to the use of 
much larger samples with high power to detect even very small associations and as well as the 
enforcement of replication.  This has been accomplished through the development of large-
scale consortia, which have amassed samples in the tens or hundreds of thousands (see Box 
1).  There are examples of successful consortia in neuroimaging, including the 1000 Functional 
Connectomes Project and its International Neuroimaging Data-sharing Initiative (INDI)3,26  and 
the ENIGMA (Enhancing Neuro Imaging Genetics by Meta-Analysis) consortium27.  With such 
consortia come inevitable challenges of authorship and credit28, but here again we can look to 
other areas of research that have met these challenges. 
 
In some cases, researchers must necessarily use an insufficient sample size in a study, due to 
limitations in the specific sample (for example, when studying a rare patient group). In such 
cases, there are three commonly used options to improve power. First, researchers can choose 
to collect a much larger amount of data from each individual, and present results at the 
individual level rather than at the group level29,30--though the resulting inferences cannot then be 
generalized to the population as a whole. Second, researchers can use more liberal statistical 
thresholding procedures, such as methods controlling the false discovery rate (FDR).  However, 
it should be noted that the resulting higher power comes at the expense of more false positive 
results and should therefore be used with caution; any results must be presented with the 
caveat that they have an inflated false positive rate.  Third, researchers may restrict the search 
space using a small number of a priori regions of interest (ROIs) or an independent ‘functional 
localizer’ (a separate scan used to identify regions based on their functional response, such as 
retinotopic visual areas or face-responsive regions) to identify specific ROIs for each individual. 
It is essential that these ROIs (or a specific functional localizer strategy) be explicitly defined 
before any analyses. This is important because it is always possible to develop a post hoc 
justification for any specific ROI on the basis of previously published papers — a strategy that 
results in an ROI that appears independent but actually has a circular definition and thus leads 
to meaningless statistics and inflated Type I errors. By analogy to the idea of HARKing 
(hypothesizing after results are known; in which the results of exploratory analyses are 
presented as having been hypothesized from the beginning)31, we refer to this as SHARKing 
(selecting hypothesized areas after results are known).  We would only recommend the use of 
restricted search spaces if the exact ROIs and hypotheses are pre-registered32,33.  
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Finally, we note the potential for Bayesian methods to make the best use of small, 
underpowered samples.  These approaches stabilize low-information estimates, shrinking them 
towards anticipated values characterized by prior distributions. While Bayesian methods have 
not been widely used in the whole-brain setting due to the computational challenge of specifying 
a joint model over all voxels, GPU’s may provide the acceleration needed to make these 
methods practical (e.g.34). These methods also require the specification of priors, which often 
remains a challenge. 
 
Problem: Flexibility in data analysis 
 
The typical fMRI analysis workflow contains a large number of preprocessing and analysis 
operations, each with choices to be made about parameters and/or methods (see Box 3). 
Carp35 applied 6,912 analysis workflows (using the SPM36 and AFNI37 software packages) to a 
single data set and quantified the variability in resulting statistical maps. This revealed that 
some brain regions exhibited more substantial variation across the different workflows than did 
other regions. This issue is not unique to fMRI; for example, similar issues have been raised in 
genetics38. These “researcher degrees of freedom” can lead to substantial inflation of Type I 
error rates8 whenever an analysis decision is made based partly on the observed data--even 
when there is no intentional “p-hacking”, and only a single analysis is ever conducted9.  
 
Exploration is key to scientific discovery, but rarely does a research paper comprehensively 
describe the actual process of exploration that led to the ultimate result; to do so would render 
the resulting narrative far too complex and murky. As a clean and simple narrative has become 
an essential component of publication, the intellectual journey of the research is often obscured. 
Instead, reports often engage in HARKing31. Because HARKing hides the number of data-driven 
choices made during analysis, it can strongly overstate the actual evidence for a hypothesis. 
There is arguably a great need to support the publication of exploratory studies without forcing 
those studies to masquerade as hypothesis-driven science, while at the same time realizing that 
such exploratory findings (like all scientific results) will ultimately require further validation in 
independent studies. 
 
Solutions: 
We recommend pre-registration of methods and analysis plans. The details to be pre-registered 
should include planned sample size, specific analysis tools to be used, specification of predicted 
outcomes, and definition of any ROIs that will be used for analysis. The Open Science 
Framework (http://osf.io) and AsPredicted.org provide established platforms for pre-registration; 
the former allows an embargo period in which the registration remains private, obviating some 
concerns about ideas being disclosed while still under investigation. In addition, some journals 
now provide the ability to submit a “Registered Report”, in which the hypotheses and methods 
are reviewed prior to data collection, and the study is guaranteed publication regardless of the 
outcome39; see 40,41 for examples of such reports, and https://osf.io/8mpji/wiki/home/ for a list of 
journals offering the Registered Report format.  Exploratory analyses (including any deviations 
from planned analyses) should be clearly distinguished from planned analyses in the 
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publication. Ideally, results from exploratory analyses should be confirmed in an independent 
validation data set. 
 
While there are concerns regarding the degree to which flexibility in data analysis may result in 
inflated error rates, we do not believe that the solution should be to constrain researchers by 
specifying a particular set of methods that must be used.  Many of the most interesting findings 
in fMRI have come from the use of novel analysis methods, and we do not believe that there will 
be a single best workflow for all studies; in fact, there is direct evidence that different studies or 
individuals will likely benefit from different workflows 42. We believe that the best solution is to 
allow flexibility, but require that all exploratory analyses be clearly labeled as such, and strongly 
encourage validation of exploratory results (e.g. through the use of a separate validation 
dataset). 
 
Problem: Multiple comparisons 
 
The most common approach to neuroimaging analysis involves “mass univariate” testing in 
which a separate hypothesis test is performed for each voxel. In such an approach, the false 
positive rate will be inflated if there is no correction for multiple tests.  A humorous example of 
this was seen in the now-infamous “dead salmon” study reported by Bennett and colleagues43, 
in which “activation” was detected in the brain of a dead salmon, which disappeared when the 
proper corrections for multiple comparisons were performed.   
 
Figure 2 presents a similar example in which random data can be analysed (incorrectly) to lead 
to seemingly impressive results, through a combination of failure to adequately correct for 
multiple comparisons and circular ROI analysis. We generated random simulated fMRI and 
behavioral data from a Gaussian distribution (mean±standard deviation = 1000±100 for fMRI 
data, 100±1 for behavioral data) for 28 simulated subjects (based on the median sample size 
found in the analysis of Figure 1 for studies from 2015). For the fMRI data, we simulated 
statistical values at each voxel for a comparison of activation and baseline conditions for each of 
the simulated subjects within the standard MNI152 mask, and then spatially smoothed the 
image with a 6mm Gaussian kernel, based on the common smoothing level of 3 times the voxel 
size. A univariate analysis was performed using FSL to assess the correlation between 
activation in each voxel and the simulated behavioural regressor across subjects, and the 
resulting statistical map was thresholded at p < 0.001 and with a 10-voxel extent threshold 
(which is a common heuristic correction shown by Eklund et al.44 to result in highly inflated 
levels of false positives). This approach revealed a cluster of false positive activation in the 
superior temporal cortex in which the simulated fMRI data are highly correlated with the 
simulated behavioural regressor (Fig. 2a).  
 
The problem of multiplicity was recognized very early, and the last 25 years have seen the 
development of well-established and validated methods for correction of familywise error and 
false discovery rate in neuroimaging data45.  However, recent work44 has suggested that even 
some very well-established inferential methods based on spatial extent of activations can 
produce inflated Type I error rates in certain settings.   
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-- Figure 2 about here-- 
 
There is an ongoing debate between neuroimaging researchers who feel that conventional 
approaches to multiple comparison correction are too lax and allow too many false positives46, 
and those who feel that thresholds are too conservative, and risk missing most of the interesting 
effects47. In our view, the deeper problem is the inconsistent application of principled correction 
approaches48. Many researchers freely combine different approaches and thresholds in ways 
that produce a high number of undocumented researcher degrees of freedom8, rendering 
reported p-values uninterpretable.  
 
To assess this more directly, we examined the top 100 results for the Pubmed query ("fMRI" 
AND brain AND activation NOT review[PT] AND human[MESH] AND english[la]), performed 
May 23, 2016; of these, 65 reported whole-brain task fMRI results and were available in full text 
(full list of papers and annotations available at https://osf.io/spr9a/).  Only three presented fully 
uncorrected results, with four others presenting a mixture of corrected and uncorrected results; 
this suggests that corrections for multiple comparisons are now standard.  However, there is 
evidence that researchers may engage in “method-shopping” for techniques that provide greater 
sensitivity, at a potential cost of increased error rates. Nine of the 65 papers used the FSL or 
SPM software packages to perform their primary analysis, but then used the alphasim or 
3dClustSim tools from the AFNI software package (7 papers) or other simulation-based 
approaches (2 papers) to correct for multiple comparisons. This is concerning, because both 
FSL and SPM offer well-established methods that use Gaussian random field theory or 
nonparametric analyses to correct for multiple comparisons. Given the substantial degree of 
extra work (e.g. software installation, file reformatting) involved in using multiple software 
packages, the use of a different tool raises some concern that this might reflect analytic p-
hacking. This concern is further amplified by the finding that until very recently, this AFNI 
program had slightly inflated inflated Type I error rates44.  Distressingly, whereas nonparametric 
(randomization/permutation) methods are known to provide the more accurate control over 
familywise error rates compared to parametric methods45,49 and are applicable for nearly all 
models, they were not used in any of these papers. 
 
 
Solutions: 
To balance Type I and Type II error rates in a principled way, we suggest a dual approach of 
reporting corrected whole-brain results, and (for potential use in later meta-analyses) sharing a 
copy of the unthresholded statistical map (preferably Z values) through a repository that allows 
viewing and downloading (such as Neurovault.org50). For an example of this practice, see ref. 51 
and shared data at http://neurovault.org/collections/122/. Any use of non-standard methods for 
correction of multiple comparisons (for example, using tools from different packages for the 
main analysis and the multiple comparison correction) should be justified explicitly (and 
reviewers should demand such justification).  Both voxel- and cluster-wise inferences with FWE 
or FDR correction are suitable to control false positive risk, though cluster-wise and any FDR 
inferences need to be interpreted with care as they allow more false positive voxels than voxel-
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wise FWE under typical parameterizations.  
 
Alternatively one can abandon the mass univariate approach altogether. Multivariate methods 
that treat the entire brain as the measurement (e.g.52), and graph-based approaches that 
integrate information over all edges (e.g.53) avoid the multiple testing problem.  However, these 
approaches then make it challenging to understand the involvement of individual voxels/edges 
in an effect54 and raise other interpretation issues.  
  
 
Problem: Software errors 
 
As the complexity of a software program increases, the likelihood of undiscovered bugs quickly 
reaches certainty55, which implies that all software used for fMRI analysis is likely to have bugs.  
Most fMRI researchers use one of several open-source analysis packages for preprocessing 
and statistical analyses; many additional analyses require custom programs.  Because most 
researchers writing custom code are not trained in software engineering, there is insufficient 
attention to good software development practices that could help catch and prevent errors. This 
issue came to the fore recently, when a 15-year-old bug was discovered in the AFNI program 
3dClustSim (and the older AlphaSim), which resulted in slightly inflated Type I error rates44,56 
(the bug was fixed in May 2015).  While small in this particular case, the impact of such bugs 
could be widespread;  for example, PubMed Central lists 1362 publications mentioning 
AlphaSim or 3dClustSim published prior to 2015 (query [("alphasim" OR "3DClustSim") AND 
1992:2014[DP] ] performed July 14, 2016). Similarly, the analyses presented in a preprint of the 
present article contained two software errors that led to different results being presented in the 
final version of the paper. The discovery of these errors led us to perform a code review and to 
include software tests in order to reduce the likelihood of remaining errors. Even though 
software errors will happen in commonly used toolboxes as well as in-house code, they are 
much more likely to be discovered in widely used packages due to scrutiny by many more 
users. It is very likely that significant bugs exist in custom software built for individual projects, 
but due to the limited user base those bugs will never be unearthed.  
 
Solutions: 
Researchers should avoid the trap of the “not invented here” philosophy: When the problem at 
hand can be solved using software tools from a well-established project, these should be 
chosen instead of re-implementing the same method in custom code. Errors are more likely to 
be discovered when code has a larger userbase, and larger projects are more likely to follow 
better software-development practices.  Researchers should learn and implement good 
programming practices, including the judicious use of software testing and validation. Validation 
methodologies (such as comparing with another existing implementation or using simulated 
data) should be clearly defined. Custom analysis code should always be shared upon 
manuscript submission (for an example, see57). It may be unrealistic to expect reviewers to 
evaluate code in addition to the manuscript itself, although this is standard in some journals 
such as the Journal of Statistical Software.  However, reviewers should request that the code be 
made available publicly (so others can evaluate it) and in case of methodological papers that 
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the code is accompanied with a set of automated tests. Finally, researchers need to acquire 
sufficient training on the implemented analysis methods, in particular so they understand the 
software’s default parameter values, as well as the assumptions on the data and how to verify 
those assumptions. 
 
 
Problem: Insufficient study reporting 
 
In order to know whether appropriate analyses have been performed, the methods must be 
reported in sufficient detail.  Eight years ago we58 published an initial set of guidelines for 
reporting the methods used in an fMRI study.  Unfortunately, reporting standards in the fMRI 
literature remain poor.  Carp59 and Guo and colleagues60 analyzed 241 and 100 fMRI papers 
respectively for the reporting of methodological details, and both found that some important 
analysis details (e.g. interpolation methods, smoothness estimates) were rarely described.  
Consistent with this, in 22 of the 65 papers discussed above it was impossible to identify exactly 
which multiple comparison correction technique was used (beyond generic terms such as 
“cluster-based correction”) because no specific method or citation was provided. The 
Organization for Human Brain Mapping has recently addressed this issue through its 2015–
2016 Committee on Best Practices in Data Analysis and Sharing (COBIDAS), which has issued 
a new, detailed set of reporting guidelines61 (http://www.humanbrainmapping.org/COBIDAS) 
(see Box 4).   
 
Beyond the description of methods, claims in the neuroimaging literature are often advanced 
without corresponding statistical support. In particular, failures to observe a significant effect 
often lead researchers to proclaim the absence of an effect—a dangerous and almost invariably 
unsupported acceptance of the null hypothesis. “Reverse inference” claims, in which the 
presence a given pattern of brain activity is taken to imply a specific cognitive process (e.g., “the 
anterior insula was activated, suggesting that subjects experienced empathy”), are rarely 
grounded in quantitative evidence15,62. Furthermore, claims of “selective” activation in one brain 
region or experimental condition are often made when activation is statistically significant in one 
region or condition but not in others—ignoring the fact that “the difference between significant 
and non-significant is not itself significant”63 and in the absence of appropriate tests for 
statistical interactions64. 
 
Solutions: 
Authors should follow accepted standards for reporting methods (such as the COBIDAS 
standard for MRI studies), and journals should require adherence to these standards. Every 
major claim in a paper should be directly supported by appropriate statistical evidence, including 
specific tests for significance across conditions and relevant tests for interactions. Because the 
computer code is often necessary to understand exactly how a dataset has been analyzed, 
releasing the analysis code is particularly useful and should be adopted as a standard practice.  
 
 
Problem: Lack of independent replications 
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There are surprisingly few examples of direct replication in the field of neuroimaging, likely 
reflecting both the expense of fMRI studies along with the emphasis of most top journals on 
novelty rather than informativeness. While there are many basic results that are clearly 
replicable (e.g. presence of face-selective vs. scene-selective activation in ventral temporal 
cortex, or systematic correlations within functional networks during the resting state), the 
replicability of more subtle and less neurobiologically established effects (such as group 
differences and between-subject correlations) is nowhere near as certain. One study65,66 
attempted to replicate 17 studies that had previously found associations between brain structure 
and behaviour. Only one of the 17 replication attempts showed stronger evidence for an effect 
as large the original effect size rather than for a null effect, and 8 out of 17 showed stronger 
evidence for a null effect. This suggests that replicability of neuroimaging findings (particularly 
brain-behavior correlations) may be exceedingly low, similar to recent findings in other areas of 
science such as cancer biology67 and psychology68. 
 
It is worth noting that even though the cost of conducting an new fMRI experiment is a factor 
limiting the feasibility of replications studies there are many findings that can be replicated using 
publicly available data. Resources such as FCP-INDI26, CoRR69, OpenfMRI70, or the Human 
Connectome Project19 provide MRI data suitable to attempt to replicate many previously 
reported findings. They can also be used to answer questions about sensitivity of of a particular 
finding to the data analysis tools used35.  However, even in the cases when a replications are 
possible using publicly available data they are still rare and far apart, because the academic 
community puts much bigger emphasis on novelty of findings rather than their replicability. 
 
Solutions: 
The neuroimaging community should acknowledge replication reports as scientifically important 
research outcomes that are essential in advancing knowledge. One such attempt is the OHBM 
Replication Award to be awarded in 2017 for the best neuroimaging replication study in the 
previous year. In addition, in case of especially surprising findings (for example extra-sensory 
perception), findings that could have influence on public health policy or medical treatment 
decisions, or findings that could be tested using data from another existing dataset, reviewers 
should consider requesting replication of the finding by the group before accepting the 
manuscript. 
 
Towards the neuroimaging paper of the future 
 
In the foregoing we have outlined a number of problems with current practice and made 
suggestions for improvements.  Here we outline what we would like to see in the “neuroimaging 
paper of the future”, inspired by related work in the geosciences71. 
 
Planning.  The sample size for the study would be determined in advance using formal 
statistical power analysis. The entire analysis plan would be formally pre-registered, including 
inclusion/exclusion criteria, software workflows including contrasts and multiple comparison 
methods, and specific definitions for all planned regions of interest.  
; 
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Implementation.  All code for data collection and analysis would be stored in a version control 
system, and would include software tests to detect common problems.  The repository would 
use a continuous integration system to ensure that each revision of the code passes the 
appropriate software tests.  The entire analysis workflow (including both successful and failed 
analyses) would be completely automated within a workflow engine and packaged within a 
software container or virtual machine in order to ensure computational reproducibility.  All 
datasets and results would be assigned version numbers in order to allow explicit tracking of 
provenance.  Automated quality control would assess the analysis at each stage to detect 
potential errors. 
 
Validation.  For empirical papers, all exploratory results would be validated against an 
independent validation dataset that was not examined prior to validation.  For methodological 
papers, the approach would follow best practices for reducing overly optimistic results72.  Any 
new method would be validated against benchmark datasets and compared to other state-of-
the-art methods. 
 
Dissemination.  All results would be clearly marked as either hypothesis driven (with a link to the 
appropriate pre-registration) or exploratory. All analyses performed on the dataset (including 
those that failed) would be reported.  The paper would be written using a literate programming 
technique, in which the code for figure generation is embedded within the paper and the image 
data depicted in figures is transparently accessible.  The paper would be distributed along with 
the full codebase to perform the analyses and the data necessary to reproduce the analyses, 
preferably in a container or virtual machine to allow direct reproducibility.  Both unthresholded 
statistical maps and the raw data would be shared via appropriate community repositories, and 
the shared raw data would be formatted according to a community standard, such as the Brain 
Imaging Data Structure (BIDS)73, and annotated using an appropriate ontology to allow 
automated meta-analysis.  
 
Conclusion 
 
We have outlined what we see as a set of problems with neuroimaging methodology and 
reporting and approaches to address them.  It is likely that the reproducibility of neuroimaging 
research is no better than many other fields, where it has been shown to be surprisingly low. 
Given the substantial amount of research funds currently invested in neuroimaging research, we 
believe that it is essential that the field address the issues raised here, so as to ensure that 
public funds are spent effectively and in ways that advance our understanding of the human 
brain.  We have also laid out what we see as a roadmap for how neuroimaging researchers can 
overcome these problems, laying the groundwork for a scientific future that is transparent and 
reproducible. 
 
Further information 
 
Fmripower: fmripower.org 
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Human Connectome Project: https://www.humanconnectome.org/ 
Organisation for Human Brain Mapping (OHBM): www.humanbrainmapping.org 
NeuroPower: neuropowertools.org 
Neurosynth: http://neurosynth.org/ 
Neurovault: http://neurovault.org/  
 
 
Text Boxes: 
 
Box 1: Lessons from Genetics 
 
The study of genetic influences on complex traits has been transformed by the advent of whole 
genome methods, and the subsequent use of stringent statistical criteria, independent 
replication, large collaborative consortia, and complete reporting of statistical results. Previously, 
“candidate” genes would be selected on the basis of known or presumed biology, and a handful 
of variants genotyped (many of which would go unreported) and tested in small studies. An 
enormous literature proliferated, but these findings generally failed to replicate74. The 
transformation brought about by genome wide association studies applied in very large 
populations was necessitated by the stringent statistical significance criteria required by 
simultaneous testing of several hundred thousand genetic loci, and an emerging awareness that 
any effects of common genetic variants generally are very small ( <1% phenotypic variance). To 
realise the very large sample sizes required, large-scale collaboration and data sharing was 
embraced by the genetics community. The resulting cultural shift has rapidly transformed our 
understanding of the genetic architecture of complex traits, and in a few years produced many 
hundred more reproducible findings than in the previous fifteen years75! Routine sharing of 
single nucleotide polymorphism (SNP)-level statistical results has facilitated routine use of meta-
analysis, as well as the development of novel methods of secondary analysis76.  
 
This relatively rosy picture contrasts markedly with the situation in “imaging genetics”--a 
burgeoning field that has yet to embrace the standards commonly followed in the broader 
genetics literature, and which remains largely focused on individual candidate gene association 
studies, which are characterized by numerous researcher degrees of freedom.  To illustrate, we 
examined the first 50 abstracts matching a PubMed search for “fMRI” and “genetics” (excluding 
reviews, studies of genetic disorders, and nonhuman studies) which included a genetic 
association analysis (for list of search results, see https://osf.io/spr9a/).  Of these, the vast 
majority (43/50) reported analysis of a single or small number (5 or fewer) of candidate genes; 
only 2/50 reported a genome-wide analysis, with the rest reporting analyses using biologically 
inspired gene sets (3/50) or polygenic risk scores (2/50). Recent empirical evidence also casts 
doubt on the validity of candidate gene associations in imaging genomics.  A large genome-
wide association study of whole-brain and hippocampal volume77 identified two genetic 
associations that were both replicated across two large samples each containing more than 
10,000 individuals.  Strikingly, analysis of a set of candidate genes previously reported in the 
literature showed no evidence for any association in this very well-powered study77.  The 
lessons for imaging from genome-wide association studies more generally seems clear: 
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associations of common genetic variants with complex behavioual phenotypes are generally 
very small (<1% of phenotypic variance) and thus require large, homogeneous samples to be 
able to identify them robustly.  As the prior odds for association of any given genetic variant with 
novel imaging phenotypes generally are low, and given the large number of variants 
simultaneously tested in a genome-wide association study (necessitating a corrected P-value 
threshold of ~10-8), adequate statistical power can only be achieved by using sample sizes in 
the many thousands to tens of thousands. Finally, results need to be replicated to ensure robust 
discoveries. 
 
Box 2: Effect-size estimates for common neuroimaging experimental paradigms. 
The aim of this analysis is to estimate the magnitude of typical effect sizes of blood oxygen 
level-dependent changes in fMRI signal associated with common psychological paradigms. We 
focus on four experiments administered by the Human Connectome Project (HCP)78: an 
emotion task, gambling task, working memory task and motor task (detailed below). We chose 
data from the HCP for its large sample size, which allows computation of stable effect size 
estimates, and its diverse set of activation tasks.  The data and code used for this analysis are 
available at https://osf.io/spr9a/ .  
 
Briefly, the processing of data from the Human Connectome Project was carried out in 4 main 
steps: 
 
1. Subject Selection: The analyses are performed on the 500 subjects release of the HCP 
data, freely available at www.humanconnectome.org. We selected 186 independent subjects 
from the HCP data on the bases that (1) all subjects have results for all four of the tasks and (2) 
there are no genetically related subjects in the analysis. 
 
2. Group Analyses: The first-level analyses, which summarise the relation between the 
experimental design and the measured time series for each subject, were obtained from the 
Human Connectome Project. The processing and analysis pipelines for these analyses are 
shared together with the data. Here we perform second-level analyses — that is, an 
assessment of the average effect of the task on BOLD signal over subjects  — using the FSL 
program flame117 which performs a linear mixed-effects regression at each voxel, using 
generalized least squares with a local estimate of random effects variance. This analysis 
averages over subjects, while separating within-subject and between-subject variability to 
ensure control of unobserved heterogeneity.  
 
The specific contrasts that were tested are: 
● Motor: average BOLD response for tongue, hand and foot movements versus 
rest 
● Emotion: viewing faces with a fearful expression versus viewing neutral faces 
● Gambling: monetary reward versus punishment 
● Working memory: a contrast between conditions in which the participants 
indicate whether the current stimulus matches the one from 2 trials earlier (“2-
15 
back”), versus a condition where the participants indicate whether the current 
stimulus matches a specific target (“0-back”) 
 
3. Create Masks: The masks used for the analyses are the intersections of anatomical and a 
priori functional masks for each contrast. The rationale behind this is to find effect sizes in 
regions that are functionally related to the task, but restricted to certain anatomical regions. 
 
● Functional: We created masks using www.neurosynth.org79. To do this, we 
performed forward inference meta-analysis using the respective search terms 
"Motor","Emotion","Gambling","Working memory" for each of the tasks, with 
false discovery rate (FDR) control at 0.01, the default threshold on neurosynth.  
The resulting mask identifies voxels consistently found to be activated in 
studies that mention each of the search terms in their abstract. 
● Anatomical: We have used Harvard-Oxford probabilistic atlas22 at p>0. 
Regions were chosen for each task based on the published a priori 
hypothesized regions from the HCP23. The size of the masks was assessed by 
the number of voxels in the mask. 
 
Task Anatomical Mask 
Motor ● Precentral gyrus 
● Supplementary motor cortex 
● Left putamen 
● Right putamen 
Working memory Middle frontal gyrus 
Emotion ● Left amygdala 
● Right amygdala 
Gambling ● Left accumbens 
● Right accumbens 
 
4. Compute Effect Size: The intersection masks created above were used to isolate the 
regions of interest in the second-level-analysed BOLD signal data. From these mask-
isolated data sets, the size of the task-related effect (Cohen’s D) were computed for each 
relevant region(see Figure B2 below). FSL’s Featquery computes for each voxel the % 
BOLD change in the data within the masks.  
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Figure B2: The distributions of the observed effect size estimates and BOLD signal change 
estimates for common experimental paradigms, across voxels within each ROI (number in 
parentheses denotes the number of voxels in the ROI).  The boxplot inside the violins represent 
the interquartile range (first quartile to third quartile) and the white dot shows the median value. 
 
     
      
         
         
         
         
         
         
         
         
         
 
Box 3: Flexibility in fMRI data analysis 
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In the early days of fMRI analysis, it was rare to find two laboratories that used the same 
software to analyze their data, with most using locally-developed custom software.  Over time, a 
small number of open-source analysis packages have gained prominence (SPM, FSL, and 
AFNI being the most common), and now most laboratories use one of these packages for their 
primary data processing and analysis.  Within each of these packages, there is a great deal of 
flexibility in how data are analyzed; in some cases there are clear best practices, but in other 
cases there is no consensus regarding the optimal approach. This leads to a multiplicity of 
analysis options. In Table B1 we outline some of the major choices involved in performing 
analyses using one of the common software packages (FSL).  Even for this non-exhaustive list 
from a single analysis package, the number of possible analysis workflows exceeds the number 
of papers that have been published on fMRI since its inception more than two decades ago!  
 
It is possible that many of these alternative pipelines could lead to very similar results, though 
the analyses of Carp35 suggest that many of them may lead to significant heterogeneity in the 
results. In addition, there is evidence that choices of preprocessing parameters may interact 
with the statistical modeling approach (e.g., interactions between head motion modeling and 
physiological noise correction), and that the optimal preprocessing pipeline may differ across 
subjects (e.g. interacting with the amount of head motion)42. 
 
Table B3: A non-exhaustive list of data processing/analysis options available within the FSL 
software package, enumerating a total of 69,120 different possible workflows. 
 
Processing step Reason Options [suboptions] Number of 
plausible 
options 
Motion correction Correct for head motion 
during scanning 
Interpolation [linear vs. 
sinc] 
Reference volume [single 
vs. mean] 
4 
Slice timing 
correction 
Correct for differences in 
acquisition timing of different 
slices 
No/before motion 
correction/after motion 
correction 
3 
 
Field map 
correction 
Correct for distortion due to 
magnetic susceptibility 
Yes/No 2 
Spatial smoothing Increase SNR for larger 
activations and ensure 
assumptions of Gaussian 
random field theory 
FWHM [4/6/8 mm] 3 
Spatial 
normalization 
Warp individual brain to 
match a group template 
Method [linear/nonlinear] 
 
2 
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High pass filter  Remove low-frequency 
nuisance signals from data 
Frequency cutoff [100 secs, 
120 secs] 
2 
Head motion 
regressors 
Remove remaining signals 
due to head motion via 
statistical model 
Yes/No 
If Yes: 6/12/24 parameters 
or single timepoint 
“scrubbing” regressors 
5 
Hemodynamic 
response 
Account for delayed nature 
of hemodynamic response to 
neuronal activity 
Basis function [single-
gamma, double-gamma] 
Derivatives 
[none/shift/dispersion] 
6 
Temporal 
autocorrelation 
model 
Model for the temporal 
autocorrelation inherent in 
fMRI signals. 
Yes/no 2 
Multiple 
comparison 
correction 
Correct for large number of 
comparisons across the 
brain 
Voxel-based GRF, Cluster-
based GRF, FDR, 
nonparameteric 
4 
Total possible 
workflows 
  69,120 
 
 
Box 4: Guidelines for transparent methods reporting in neuroimaging. 
 
The OHBM COBIDAS report provides a set of best practices for reporting and conducting 
studies using MRI.  It divides practice into seven categories, and provides detailed checklists 
that can be consulted when planning, analyzing and writing up a study.  The table below lists 
these categories with summaries of the topics covered in the checklists. 
 
Acquisition Reporting 
Subject preparation. Mock scanning. Special accommodations. Experimenter personnel.  
MRI system description. Scanner. Coil. Significant hardware modifications. Software version.  
MRI acquisition. Pulse sequence type. Imaging type. Essential sequence & imaging parameters. 
Phase encoding. Parallel imaging method & parameters. Multiband parameters. Readout 
parameters. Fat suppression. Shimming. Slice order & timing. Slice position procedure. Brain 
coverage. Scanner-side preprocessing. Scan duration. Other non-standard procedures. T1 
stabilization. Diffusion MRI gradient table. Perfusion: Arterial Spin Labeling MRI. Perfusion: Dynamic 
Susceptibility Contrast MRI.  
Preliminary quality control. Motion monitoring. Incidental findings. 
Preprocessing Reporting 
General. Intensity correction. Intensity normalization. Distortion correction. Brain extraction. 
Segmentation. Spatial smoothing. Artifact and structured noise removal. Quality control reports. 
Intersubject registration.  
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Temporal/Dynamic. Motion correction.  
fMRI. T1 stabilization. Slice time correction. Function-structure (intra-subject) coregistration. 
Function-structure (intra-subject) coregistration. Volume censoring. Resting state fMRI feature.  
Diffusion. Gradient distortion correction. Diffusion MRI eddy current correction. Diffusion estimation. 
Diffusion processing. Diffusion tractography.  
Perfusion. Arterial Spin Labeling. Dynamic Susceptibility Contrast MRI 
Statistical Modeling & Inference 
Mass univariate analyses. Variable submitted to statistical modeling. Spatial region modeled. 
Independent variables. Model type. Model settings. Inference: Contrast/effect. Inference: Search 
region. Inference: Statistic type. Inference: P-value computation. Inference: Multiple testing 
correction.  
Functional connectivity. Confound adjustment & filtering. Multivariate method: Independent 
Component Analysis. Dependent variable definition. Functional connectivity measure/ model. 
Effectivity connectivity. Graph analysis.  
Multivariate modeling & predictive analysis. Independent variables. Features extraction and 
dimension reduction. Model. Learning method. Training procedure. Evaluation metrics: Discrete 
response. Evaluation metrics: Continuous response. Evaluation metrics: Representational similarity 
analysis. Evaluation metrics: Significance. Fit interpretation. 
Results Reporting 
Mass univariate analysis. Effects tested. Extracted data. Tables of coordinates. Thresholded maps. 
Unthresholded maps. Extracted data. Spatial features.  
Functional connectivity. ICA analyses. Graph analyses: Null hypothesis tested.  
Multivariate modeling & predictive analysis. Optimized evaluation metrics. 
Data Sharing 
Define data sharing plan early. Material shared. URL (access information). Ethics compliance. 
Documentation. Data format.  
Database for organized data. Quality Control procedures. Ontologies. Visualization. De-
identification. Provenance and history. Interoperability. Querying. Versioning. Sustainability plan 
(funding). 
Reproducibility 
Documentation. Tools used. Infrastructure. Workflow. Provenance trace. Literate program 
implementing results. English language version.  
Archiving. Tools availability. Virtual appliances.  
Citation. Data. Workflow. 
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Figure 1 | Sample size estimates and estimated power for fMRI studies. a | 1131 sample 
sizes over more than 20 years obtained from two sources: 583 sample sizes by manual 
extraction from published meta-analyses by David et al.14, and 548 sample sizes obtained by 
automated extraction from the Neurosynth database15 with manual verification. These data 
demonstrate that sample sizes have steadily increased over the last two decades, with a 
median estimated sample size of 28.5 as of 2015. b | Using the sample sizes from the left panel, 
we estimated the standardized effect size required to detect an effect with 80% power for a 
whole-brain linear mixed-effects analysis using a voxelwise 5% familywise error rate threshold 
from random field theory16 (see main text for details). Median effect size for which studies were 
powered to find in 2015 was 0.75.  Data and code to generate these figures are available at 
https://osf.io/spr9a/ ; see Supplementary materials for a version with all datapoints depicted. 
 
 
Figure 2: Small samples, uncorrected statistics and circularity can produce misleadingly 
large effects. 
Seemingly impressive brain-behavior association can arise from completely random data 
through the use of uncorrected statistics and circular ROI analysis to capitalize on the large 
sampling error arising from small samples.  With the informal P<0.001 and cluster size k>10 
thresholding, the analysis revealed a cluster in the superior temporal gyrus (left panel); signal 
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extracted from that cluster (i.e., using circular analysis) showed a very strong correlation 
between brain and behavior (right panel; r = 0.87).  See main text for details of the analysis.  A 
computational notebook for this example is available at https://osf.io/spr9a/.  
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Supplementary Materials 
 
Figure S1: A depiction of the data from Figure 1 showing all data points.  Sample sizes are 
shown on a log scale. 
 
 
 
